Browse by Creator

Article

May, J. E. , Pemberton, R. , Hart, J. P. , McLeod, J. D. , Wilcock, G. and Doran, O. (2012) Use of whole blood for analysis of disease-associated biomarkers. To be published in Analytical Biochemistry. ISSN 0003-2697 [In Press]

Kehoe, P. and Wilcock, G. (2007) Is inhibition of the renin–angiotensin system a new treatment option for Alzheimer s disease. The Lancet Neurology , 6 (4). pp. 373-378.

Vellas, B. , Sampaio, C. , Andrieu, S. and Wilcock, G. (2007) Disease-modifying trials in Alzheimer s disease a European task force consensus. The Lancet Neurology, 6 (1). pp. 56-62.

Tales, A. , Brown, M. , Snowden, R. and Wilcock, G. (2006) Alerting and Orienting in Alzheimer s Disease. Neuropsychology, 20 (6). pp. 752-756.

Hughes, A. , Culpan, D. , Price, J. , Palmer, L. , Kehoe, P. , Love, S. , Matthews, S. and Wilcock, G. (2006) Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer s disease. Neuroscience letters, 13 (2). pp. 141-5.

Miners, J. , Chalmers, K. , Kehoe, P. , Love, S. , Helmond, Z. and Wilcock, G. (2006) Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. Journal of Neuropathology & Experimental Neurology, 65 (10). pp. 1012-1021.

Byrne-Davis, L. , Bennett, P. and Wilcock, G. (2006) How are Quality of Life Ratings Made Toward a Model of Quality of Life in People with Dementia. Quality of Life Research, 15 (5). pp. 855-865.

Shlomo, B. , Dawbarn, D. , Siew, L. , Love, S. , Allen, S. and Wilcock, G. (2006) Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiology of Aging , 27 (6). pp. 797-803.

Burns, A. , McCaddon, A. , Thomas, A. , Ballard, C. , Jacova, C. , Richie, C. , Wilkinson, D. , Ford, G. , Feldman, H. , O'Brien, J. , Warner, J. , Orgogozo, J. , Broich, K. , Knapp, M. , McKeith, M. , Richardson, M. , Purandare, N. , Bullock, R. , Jones, R. , Auriacombe, S. , Lennon, S. , Lliffe, S. and Wilcock, G. (2006) Clinical practice with anti-dementia drugs a consensus statement from British Association for Psychopharmacology. Journal of Psychopharmacology , 20 (6). pp. 732-755.

Wilcock, G. (2006) Dementia where has 2005 taken us . The Lancet Neurology, 5 (1). pp. 11-12.

Vreugdenhil, A. , Razay, G. and Wilcock, G. (2006) Obesity Abdominal Obesity and Alzheimer Disease. Dementia Geriatric Cognitive Disorders, 22 (2). pp. 173-176.

Chalmers, K. , Love, S. and Wilcock, G. (2005) Contributors to white matter damage in the frontal lobe in Alzheimer s disease. Neuropathology & Applied Neurobiology , 31 (6). pp. 623-631.

Baig, S. , Love, S. and Wilcock, G. (2005) Loss of perineuronal net N-acetylgalactosamine in Alzheimer s disease. Acta Neuropathol , 110 (4). pp. 393-401.

Chalmers, K. , Love, S. , Williams, S. and Wilcock, G. (2005) Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer s disease. Neuropathology & Applied Neurobiology , 31 (4). pp. 414-421.

Chalmers, K. , Blomqvist, M.-L. , Andreasen, N. , Bogdanovic, N. and Wilcock, G. (2005) Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer s disease brain. Neurobilogy of Aging, 26 (6). pp. 795-802.

Tales, A. , Haworth, R. , Snowden, R. and Wilcock, G. (2005) Abnormal spatial and non-spatial cueing effects in mild cognitive impairment and Alzheimer s disease. Neurocase, 11 (8). pp. 85-92.

Tales, A. , Haworth, J. , Nelson, S. J. , Snowden, R. and Wilcock, G. (2005) Abnormal visual search in mild cognitive impairment and Alzheimer's disease. Neurocase, 11 (1). pp. 80-84. ISSN 1355-4794

Combrinck, M. , Wozniak, M. , Itzhaki, R. , Shipley, S. and Wilcock, G. (2004) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer s disease patients. Journal of Medical Virology, 75 (2). -.

Damaraju, C. , Truyen, L. , Pirtilla, T. and Wilcock, G. (2004) Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer s disease multicenter trial. European Journal of Neurology, 11. pp. 734-41.

Whitehead, A. , Perdomo, C. , Birks, J. , Evans, J. , Prat, R. and Wilcock, G. (2004) Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer s disease a meta-analysis of individual patient data from randomised controlled trials. International Journal of Geriatric Pyschiatry, 19 (7). pp. 624-33.

Haworth, J. , Condefer, K. and Wilcock, G. (2004) Clinical utility of computed tomography in the assessment of dementia a memory clinic study. International Journal of Geriatric Psychiatry, 19 (5). pp. 414-21.

Katzov, H. , Gatz, M. , Andreasen, N. , Cairns, N. , Kehoe, P. and Wilcock, G. (2004) Common variants of ACE contribute to variable age-at-onset of Alzheimer s disease. Human Genetics, 114 (5). pp. 478-483.

Katzov, H. , Chalmers, K. , Palmgren, J. , Andreasen, N. , Johansson, B. , Cairns, N. J. , Gatz, M. , Wilcock, G. , Love, S. , Pedersen, N. L. , Brookes, A. J. , Blennow, K. , Kehoe, P. G. and Prince, J. A. (2004) Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Human Mutation, 23 (4). pp. 358-367. ISSN 1098-1004

Birks, J. and Wilcock, G. (2004) Velnacrine for Alzheimer s Disease. The Cochrane Database of Systematic Reviews , 3.

Hughes, A. , Culpan, C. , Chalmers, C. , Kehoe, P. , Love, S. and Wilcock, G. (2004) APOE promoter ACEI and CYP46 polymorphisms and &#946 -amyloid in Alzheimer s disease. Neuroreport , 15 (1). pp. 95-98.

Birks, J. , Evans, J. and Wilcock, G. (2004) Evidence-based pharmacotherapy. International Journal of Neuropsychopharmacology, 7.

Dawbarn, D. , Siew, L. , Love, S. , Allen, S. and Wilcock, G. (2004) Measurement of pre- and post-synaptic proteins in cerebral cortex effects of post-mortem delay. ournal of neuroscience methods, 139 (2). pp. 153-159.

Culpan, D. , MacGowan, S. , Ford, J. , Nicoll, J. , Griffin, W. S. , Dewar, D. , Cairns, N. , Hughes, A. , Kehoe, P. and Wilcock, G. (2003) Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease. Neuroscience Letters, 350 (1). pp. 61-65. ISSN 0304-3940

Neal, J. , Radenahmad, N. , Pearson, R. and Wilcock, G. (2003) A neurofilament antibody recognizes a subset of pyramidal cells in the human neocortex that are preserved in Alzheimer s disease. Neuropathology and Applied Neurobiology, 29 (3).

KA, C. , J, H. and Wilcock, G. (2003) Prediction rules for computed tomography in the dementia assessment do they predict clinical utility of CT. International Journal of Geriatric Psychiatry, 18 (4). -.

Brookes, A. , AM, B. , N, C. , L, F. , Katzov, H. , Prince, J. , B, J. , Blennow, K. , Kehoe, P. , De Faire, U. , B, W. and Wilcock, G. (2003) Haplotypes extending across ACE are associated with Alzheimer s disease. Human Molecular Genetics, 12 (8). pp. 859-867.

Hughes, A. , Nicoll, J. , Love, S. and Wilcock, G. (2003) APOE and cerebral amyloid angiopathy in the elderly. NeuroReport , 14. pp. 1535-1536.

Chalmers, K. , Love, S. and Wilcock, G. (2003) APOE epsilon4 influences the pathological phenotype of Alzheimer s disease by favouring cerebrovascular over parenchymal accumulation of Abeta protein. Neuropathology and Applied Neurobiology, 29 (3). pp. 231-238.

Wozniak, M. , Cookson, R. , Itzhaki, R. and Wilcock, G. (2003) Absence of Chlamydia pneumoniae in brain of vascular dementia patients. Neurobiology of Aging, 24 (6). -.

Wilcock, G. (2003) Dementia with Lewy bodies. The Lancet. pp. 1689-1690.

Wilcock, G. (2003) Effect of vitamins and aspirin on markers of platelet activation oxidative stress and homocysteine in people at high risk of dementia. Journal of Medicine, 254 (1). pp. 67-75.

Tallon, D. , Philip, J. , Vedhara, K. , Hunt, M. , Shanks, N. , Perks, P. , Bennett, P. , Murphy, P. , Jones, R. , Clark, S. , Shaw, S. , Lightman, S. and Wilcock, G. (2003) Enhancement of Antibody Responses to Influenza Vaccination in the Elderly Carers of Dementia Patients following a Cognitive-Behavioural Stress Management Intervention. Psychotherapy and Psychosomatics , 72 (5). pp. 245-252.

H, C. , Howe, I. , Truyen, L. , Bullock, R. , Lilienfield, S. , Zhu, Y. and Wilcock, G. (2003) A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer s Disease. Drugs and Aging, 20 (10). pp. 777-789.

Wilcock, G. (2003) Memantine for the treatment of dementia. Lancet Neurology, 2 (8). pp. 503-505.

R, B. , Haworth, J. , Tian, J. and Wilcock, G. (2003) Neuropsychological prediction of conversion to dementia from questionable dementia statistically significant but not yet clinically useful. Journal of Neurology Neurosurgery and Psychiatry, 74. -.

Joffres, C. , J, H. , Rockwood, R. , Bucks, R. and Wilcock, G. (2003) Patterns of Clinically Detectable Treatment Effects with Galantamine A Qualitative Analysis. Dementia and Geriatric Cognitive Disorders, 15. pp. 26-33.

Van Baelen, B. , Sano, M. and Wilcock, G. (2003) The effects of galantamine treatment on caregiver time in Alzheimer s disease. International Journal of Geriatric Psychatry, 18 (10). pp. 942-950.

Wilcock, G. (2002) alpha- and beta-secretase: profound changes in Alzheimer's disease. Biochemical and Biophysical Research Communications, 299 (3). -.

Wilcock, G. , Mobius, H. and Stoffler, A. (2002) A double-blind placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). International Clinical Psychopharmacology, 17 (6). pp. 297-305. ISSN 0268-1315

Joffres, C. , Rockwood, K. and Wilcock, G. (2002) Improving clinical descriptions to understand the effects of dementia treatment consensus recommendations. International Journal of Geriatric Psychiatry, 17 (11). -.

Taylor, G. , Vipond, I. , Paul, I. , Matthews, S. , Wilcock, G. and Caul, E. (2002) Failure to correlate C. pneumoniae with late onset alzheimers disease. Neurology, 59 (1). pp. 142-143. ISSN 0028-3878

Robertson, A. , Clarke, A. , Mason, G. , Dawbarn, G. , Burston, J. , Sessions, R. , Naylor, R. , Allen, S. , Tyler, S. and Wilcock, G. (2002) A discrete domain of the human TrkB receptor defines the binding sites for brain-derived and neurotrophic factor and neurotrophin-4. Biochemical and Biophysical Research Communications, 291 (7). pp. 501-507. ISSN 0006-291X

Wozniak, M. , Itzhaki, R. , Lin, W. and Wilcock, G. (2002) Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiology of Disease, 9 (1). pp. 82-87. ISSN 0969-9961

Jordan, A. , Hughes, A. O. , MacGowan, S. H. and Wilcock, G. (2002) Predicting progression to dementia in a memory clinic. Brain Aging International Journal, 2 (1). pp. 42-47.

Whitehead, A. , Birks, J. , Grimley-Evans, J. and Wilcock, G. (2002) The effect of selegiline in the treatment of people with Alzheimer's disease a meta-analysis of published trials. International Journal of Geriatric Psychiatry, 17 (2). pp. 175-183. ISSN 0885-6230

Van Diepen, E. , Lindesay, J. , Marudkar, M. and Wilcock, G. (2002) The second Leicester survey of memory clinics in the British Isles. International Journal of Geriatric Psychiatry, 17 (1). pp. 41-47. ISSN 0885-6230

Tales, A. , Lush, D. , Haworth, J. , Butler, S. , Troscienko, T. and Wilcock, G. (2001) The pupillary light reflex in aging and Alzheimer's disease. Aging, 13 (6). pp. 473-478. ISSN 0002-0966

Greene, J. , Neal, J. , Radenahmad, N. , Pearson, R. and Wilcock, G. (2001) Accumulation of calbindin in cortical pyramidal cells with ageing a putative protective mechanism which fails in Alzheimer's disease. Neuropathology and applied neurobiology, 27 (5). pp. 339-342. ISSN 0305-1846

Baddeley, A. , Baddeley, H. , Bucks, R. and Wilcock, G. (2001) Attentional control in Alzheimer's disease. Brain, 124 (8). pp. 1492-1508. ISSN 0006-8950

Robertson, A. , Clarke, A. , Dawbarn, D. , Bennett, G. , Mason, J. , Banfield, M. , Naylor, R. , Allen, S. , Brain, S. , Tyler, S. and Wilcock, G. (2001) Identification and structure of the nerve growth factor binding site on TrkA. Biochemical and Biophysical Research Communications, 282 (1). pp. 131-141. ISSN 0006-291X

Robertson, A. , Dawbarn, D. , Allen, S. , Tyler, S. and Wilcock, G. (2001) Recombinant human nerve growth factor for clinical trials: Protein expression purification stability and characterisation of binding to infusion pumps. Journal of Biochemical and Biophysical Methods, 47 (3). pp. 239-255. ISSN 0165-022X

Vedhara, K. , Shanks, N. , Lightman, S. L. and Wilcock, G. (2001) Correlates and predictors of self-reported psychological and physical morbidity in chronic caregiver stress. Journal of Health Psychology, 6 (1). pp. 101-119. ISSN 1359-1053

Hughes, A. , Ahmed, A. , Morris, C. , Wilcock, G. , Ford, J. , Cairns, N. , MacGowan, S. and Jones, R. (2001) N-acetyltransferase (NAT2) genotype and susceptibility to AD, PD and DLB. Alzheimer's Reports, 4. pp. 137-44.

Book Section

Wilcock, G. (2003) Brocklehurst's Textbook of Geriatric Medicine and Gerontology (Chapter 64). In: (2003) Brocklehurst's Textbook of Geriatric Medicine and Gerontology (Chapter 64). London: UNSPECIFIED. ISBN